Procept Biorobotics Corp (PRCT) Stock: What Does the Chart Say Wednesday?

The market has been high on Procept Biorobotics Corp (PRCT) stock recently. PRCT gets a Bullish score from InvestorsObserver Stock Sentiment Indicator.

Procept Biorobotics Corp has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on PRCT!

See Full PRCT Report

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With PRCT Stock Today?

Procept Biorobotics Corp (PRCT) stock is trading at $27.92 as of 1:17 PM on Wednesday, Nov 1, a rise of $1.13, or 4.2% from the previous closing price of $26.79. The stock has traded between $26.44 and $28.02 so far today. Volume today is less active than usual. So far 311,702 shares have traded compared to average volume of 441,580 shares.

More About Procept Biorobotics Corp

PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. The company's assets are primarily based in the United States. Its revenue is primarily generated from sales of the AquaBeam Robotic System and the accompanying single-use disposable handpieces. Click Here to get the full Stock Report for Procept Biorobotics Corp stock.